Clinical Report: Retinal Repair from Stem Cells

Overview

This study presents a method for deriving functional retinal endothelial cells from human induced pluripotent stem cells (hiPSCs), which can model diabetic retinopathy and repair ischemic retina in mice. The research highlights the ability of these cells to form perfusable microvascular networks.

Background

The ability to generate human retinal endothelial cells is crucial for studying the inner blood-retina barrier and developing treatments for ischemic retinal diseases. This study addresses challenges in obtaining these cells by utilizing hiPSCs to create a renewable source of retinal endothelial cells.

Data Highlights

No numerical data available in the provided source.

Key Findings

• Induced retinal endothelial cells (iRECs) were derived from hiPSCs using Wnt–β-catenin signaling.
• iRECs exhibited strong barrier properties, higher transendothelial electrical resistance, and lower permeability compared to non-tissue-specific endothelial cells.
• Under diabetic conditions, iRECs demonstrated reduced barrier function and disrupted vascular network architecture.
• In a mouse model, iREC transplantation reduced vaso-obliteration and pathological neovascularization.
• iRECs integrated with host vasculature and formed functional microvascular networks.
• The study developed an iBRB-on-a-chip model to further explore retinal endothelial cell behavior.

Clinical Implications

The findings indicate that iRECs could serve as a tool for modeling retinal diseases and testing therapies.

Conclusion

This research provides a platform for understanding retinal vascular diseases through the use of stem cell-derived endothelial cells.

Related Resources & Content

1. Retinal Physician, 2025 -- Stem Cell Therapies for Retinal Degenerations
2. The Ophthalmologist, 2026 -- Sharper Targets for Retinal Repair
3. Retinal Physician, 2023 -- An Update on Stem Cell Therapy for Retinal Diseases
4. PMC, 2026 -- Standards of Care in Diabetes
5. PubMed, 2025 -- Long-Term Effects of Anti-VEGF Therapy versus Panretinal Photocoagulation
6. International Society for Stem Cell Research -- Guidelines
7. retinal physician — Stem Cell Therapies for Retinal Degenerations
8. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 - PMC
9. Long-Term Effects of Anti-VEGF Therapy versus Panretinal Photocoagulation on Retinal Vessel Caliber in Eyes with Proliferative Diabetic Retinopathy - PubMed
10. Guidelines — International Society for Stem Cell Research